{"id":11020,"date":"2021-08-11T08:17:34","date_gmt":"2021-08-11T06:17:34","guid":{"rendered":"http:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/uncategorized-tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/"},"modified":"2022-06-17T09:03:10","modified_gmt":"2022-06-17T07:03:10","slug":"dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/","title":{"rendered":"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj"},"content":{"rendered":"<p>\u0130\u015fletimin giderek daha otonom hale gelmesi -bu konuda hemfikir oldu\u011fumuzu varsay\u0131yorum- proses end\u00fcstrisinin bir\u00e7ok b\u00f6l\u00fcm\u00fcnde gelece\u011fe damgas\u0131n\u0131 vuracak. Kesin olansa, bunun bir gecede ger\u00e7ekle\u015fmeyece\u011fi. Makul olan, bu durumun Yokogawa&#8217;n\u0131n da izledi\u011fi yol olan otonom i\u015fletime ad\u0131m ad\u0131m yakla\u015f\u0131m \u015feklinde kendisini g\u00f6stermesidir. Muhtemelen bu kadar\u0131nda hepimiz hemfikiriz. Bunun nas\u0131l olaca\u011f\u0131 ise halen bir soru i\u015fareti. \u00c7\u00fcnk\u00fc bir\u00e7ok \u015firket \u015fimdiye kadar oldu\u011fu gibi uygulamaya ge\u00e7irmekte zorlan\u0131yor. Elbette halihaz\u0131rda \u00f6nemli ilerleme kaydetmi\u015f ve geni\u015f kapsaml\u0131 pilot uygulamalar ba\u015flatm\u0131\u015f bir dizi b\u00fcy\u00fck \u015firket var. Ama onlar da \u00f6ncesinde baz\u0131 engelleri a\u015fmak zorunda kald\u0131. Nihayet proses tesislerinin otonom i\u015fletimi tek ba\u015f\u0131na ele al\u0131nacak bir \u015fey de\u011fildir. Kapsaml\u0131 bir dijital d\u00f6n\u00fc\u015f\u00fcm stratejisine entegre edilmelidir.<\/p>\n<h3><a href=\"https:\/\/cp.yokogawa.com\/Digital_Transformation-TR.html\"><img decoding=\"async\" class=\" wp-image-15686 aligncenter\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-Sage-300x170-2.jpg\" alt=\"\" width=\"365\" height=\"207\" \/><\/a>M\u00fcnferit d\u00f6n\u00fc\u015f\u00fcmlerin mevcut durumu<\/h3>\n<p>Dijital d\u00f6n\u00fc\u015f\u00fcmde kesinlikle tek bir do\u011fru yol yoktur. Ayr\u0131ca karakteristikler her sekt\u00f6re, hatta her \u015firketin kendisine hayli \u00f6zg\u00fcd\u00fcr. Ancak, \u015firketleri dijital d\u00f6n\u00fc\u015f\u00fcm yolunda ak\u0131ll\u0131ca destekleyen genel ad\u0131mlar\u0131n makul oldu\u011fu ortaya \u00e7\u0131kt\u0131.<\/p>\n<p>Bu ba\u011flamda baz\u0131 sorular\u0131n yan\u0131tlanmas\u0131 o kadar da kolay de\u011fildir. D\u00f6n\u00fc\u015f\u00fcm\u00fcn hedefleriyle, mevcut durumla ve ivedilikle kapat\u0131lmas\u0131 gereken bo\u015fluklarla ilgili sorular&#8230; Ancak ayn\u0131 zamanda hangi \u00e7\u00f6z\u00fcmlerin esasen makul oldu\u011fu ve k\u0131sa veya uzun vadede beklenen fayday\u0131 sa\u011flayaca\u011f\u0131 ya da \u00e7al\u0131\u015fanlar\u0131n uygulama i\u00e7in hangi becerilere sahip olmas\u0131 gerekti\u011fi gibi sorular. Bu gibi sorular, \u00f6zellikle \u015firketler i\u00e7in dijital d\u00f6n\u00fc\u015f\u00fcm\u00fcn hen\u00fcz ba\u015f\u0131nda b\u00fcy\u00fck zorluk te\u015fkil eder. Y\u00f6netim deste\u011finin oldu\u011funu ve en az\u0131ndan hem End\u00fcstri 4.0&#8217;a y\u00f6nelik temel bir anlay\u0131\u015f\u0131n hem de dijital d\u00f6n\u00fc\u015f\u00fcm\u00fcn kurumsal stratejiye entegrasyonunun mevcut oldu\u011funu, yani ilk ad\u0131ma hakim olundu\u011funu varsayal\u0131m. Bu durumda olgunluk derecesi modelleri yukar\u0131daki sorular\u0131 yan\u0131tlamada hayli yard\u0131mc\u0131 olabilir. Ancak daha sonra da, mevcut stratejileri de\u011fi\u015fen ko\u015fullara \u00e7evik bir \u015fekilde uyarlayabilmek i\u00e7in mevcut durumun incelenmesi esas hale gelir.<\/p>\n<h3>Olgunluk derecesi modelleri nas\u0131l yard\u0131mc\u0131 olabilir?<\/h3>\n<p>Olgunluk derecesi modellerinin ne oldu\u011funu ve \u015firketlerin kendileri i\u00e7in do\u011fru modeli nas\u0131l bulabilece\u011fini VDI\/VDE Dijital D\u00f6n\u00fc\u015f\u00fcm B\u00f6l\u00fcm\u00fc Ba\u015fkan\u0131 Dr. Violett Zeller ile konu\u015ftuk.<\/p>\n<h3>Bana uygun modeli nas\u0131l bulabilirim?<\/h3>\n<p>Baz\u0131lar\u0131 internette \u00fccretsiz olarak bulunan \u00e7ok say\u0131da olgunluk derecesi modeli vard\u0131r. Bu y\u00fczden buradan genel bir bak\u0131\u015f elde etmek ve bir \u015firketin m\u00fcnferit talepleri i\u00e7in do\u011fru olan\u0131 bulmak pek de kolay de\u011fildir. Dr. Zeller&#8217;in r\u00f6portajda belirtti\u011fi \u00fczere VDI\/VDE 4000 y\u00f6nergesi do\u011fru modeli se\u00e7menizde yard\u0131mc\u0131 olur. Dolay\u0131s\u0131yla \u015fimdilik taslak olarak mevcut olan y\u00f6nergenin i\u00e7eri\u011fine k\u0131sa bir bak\u0131\u015f atmakta fayda var. Y\u00f6nerge, karar vericilere do\u011fru End\u00fcstri 4.0 olgunluk derecesi modelini se\u00e7me konusunda bir oryantasyon sa\u011flamak \u00fczere tasarlanm\u0131\u015ft\u0131r. B\u00f6ylece kendi olgunluk derecenizi belirleyebilir ve bunu bir yol haritas\u0131 olu\u015fturmak \u00fczere temel alabilirsiniz.<\/p>\n<h3>Sayfa 1<\/h3>\n<p>konuya giri\u015f yapar, se\u00e7im kriterlerini ve model t\u00fcrlerini a\u00e7\u0131klar ve okuyucu i\u00e7in se\u00e7im esnas\u0131nda ve ayn\u0131 zamanda modellerin uygulanmas\u0131nda destek olacak temel bilgileri sa\u011flar.<\/p>\n<h3>Sayfa 2<\/h3>\n<p>pratik se\u00e7imi destekler. Farkl\u0131la\u015ft\u0131r\u0131lm\u0131\u015f karar kriterlerine g\u00f6re ele al\u0131nan olgunluk derecesi modellerinin mevcut s\u0131n\u0131fland\u0131rmas\u0131 ve bir soru katalo\u011fu temelinde okuyucu kendisine uygun modeli belirleme olana\u011f\u0131na sahip olur.<\/p>\n<h3>Sayfa 3<\/h3>\n<p>sayfa 2&#8217;de sunulan prosed\u00fcr\u00fcn uygulamas\u0131n\u0131 vaka \u00f6rnekleri arac\u0131l\u0131\u011f\u0131yla tart\u0131\u015f\u0131r. \u00d6rnek bir \u015fekilde karar verme s\u00fcrecini, modellerin uygulamas\u0131n\u0131 ve ayn\u0131 zamanda ortaya \u00e7\u0131kan bilgiyi g\u00f6sterir.<\/p>\n<p>Olgunluk derecesi modelleri, eylem alanlar\u0131n\u0131 belirlemek ve dijital d\u00f6n\u00fc\u015f\u00fcm yolunu yap\u0131land\u0131rmak i\u00e7in k\u0131ymetli ara\u00e7lard\u0131r. Dijital d\u00f6n\u00fc\u015f\u00fcmle birlikte ciro b\u00fcy\u00fcmesi, verimlilik art\u0131\u015f\u0131 veya kaynaklar\u0131 azaltma gibi hangi hedeflere ula\u015f\u0131laca\u011f\u0131 a\u00e7\u0131k olmal\u0131d\u0131r. Ayr\u0131ca baz\u0131 \u015firketler s\u00fcrd\u00fcr\u00fclebilirlik hedeflerinin pe\u015finden gitmeye ba\u015flam\u0131\u015ft\u0131r. Bu s\u00fcre\u00e7te dijitalle\u015fme, kaynaklar\u0131n korunmas\u0131n\u0131 sa\u011flayan kurumsal s\u00fcre\u00e7lerin tasarlanmas\u0131na ve buna y\u00f6nelik \u00fcr\u00fcnlerin geli\u015ftirilmesine yard\u0131mc\u0131 olabilir.<\/p>\n<p>Proses end\u00fcstrisinde dijital d\u00f6n\u00fc\u015f\u00fcme dair ba\u015fka konular da i\u00e7eren bu blogda bize kat\u0131l\u0131n.<\/p>\n<p>Bir sonraki makalede, end\u00fcstriyel otomasyondan end\u00fcstriyel otonomiye giden yol hakk\u0131nda bilgiler edinebilirsiniz.<\/p>\n<h3><a href=\"https:\/\/cp.yokogawa.com\/Digital_Transformation-TR.html\"><img decoding=\"async\" class=\" wp-image-15686 aligncenter\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-Sage-300x170-2.jpg\" alt=\"\" width=\"365\" height=\"207\" \/><\/a><\/h3>\n<hr \/>\n<blockquote class=\"wp-embedded-content\" data-secret=\"nJirMS4i7u\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/optimizasyon\/iyi-veri-iyi-para-demek-mi\/\">\u0130yi veri iyi para demek mi?<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;\u0130yi veri iyi para demek mi?&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/optimizasyon\/iyi-veri-iyi-para-demek-mi\/embed\/#?secret=cZ7kYebfXe#?secret=nJirMS4i7u\" data-secret=\"nJirMS4i7u\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"nemGjxpVbV\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/otomasyon\/akilli-uretim-sinirlar-ortadan-kalkiyor-gereklilikler-kaliyor\/\">Ak\u0131ll\u0131 \u00fcretim: S\u0131n\u0131rlar ortadan kalk\u0131yor &#8211; gereklilikler kal\u0131yor<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Ak\u0131ll\u0131 \u00fcretim: S\u0131n\u0131rlar ortadan kalk\u0131yor &#8211; gereklilikler kal\u0131yor&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/otomasyon\/akilli-uretim-sinirlar-ortadan-kalkiyor-gereklilikler-kaliyor\/embed\/#?secret=rFrSGeNyxv#?secret=nemGjxpVbV\" data-secret=\"nemGjxpVbV\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dijital d\u00f6n\u00fc\u015f\u00fcme giren \u015firketler i\u00e7in bir\u00e7ok farkl\u0131 soru b\u00fcy\u00fck zorluklar do\u011furuyor. Olgunluk modelleri, bunlara cevap vermede b\u00fcy\u00fck destek sa\u011flayabilir. Ancak daha sonra bile, mevcut stratejileri de\u011fi\u015fen ko\u015fullara \u00e7evik bir \u015fekilde adapte edebilmek i\u00e7in g\u00fcncel durumun incelenmesi \u015fartt\u0131r. #VDI \/ #VDE&hellip; <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/\"> <span class=\"screen-reader-text\">Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj<\/span> Devam\u0131 &raquo;<\/a><\/p>\n","protected":false},"author":115,"featured_media":9171,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[2061,2058],"tags":[2273,2271,2260,905],"coauthors":[222],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri - Violett Zeller ile r\u00f6portaj - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri - Violett Zeller ile r\u00f6portaj\" \/>\n<meta property=\"og:description\" content=\"Dijital d\u00f6n\u00fc\u015f\u00fcme giren \u015firketler i\u00e7in bir\u00e7ok farkl\u0131 soru b\u00fcy\u00fck zorluklar do\u011furuyor. Olgunluk modelleri, bunlara cevap vermede b\u00fcy\u00fck destek sa\u011flayabilir. Ancak daha sonra bile, mevcut stratejileri de\u011fi\u015fen ko\u015fullara \u00e7evik bir \u015fekilde adapte edebilmek i\u00e7in g\u00fcncel durumun incelenmesi \u015fartt\u0131r. #VDI \/ #VDE&hellip;  Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj Devam\u0131 &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-11T06:17:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-17T07:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"843\" \/>\n\t<meta property=\"og:image:height\" content=\"429\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Silke M\u00fcller\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/\"},\"author\":{\"name\":\"Silke M\u00fcller\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/person\/1f3b3ff3511df254fa00b2c9813ae815\"},\"headline\":\"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj\",\"datePublished\":\"2021-08-11T06:17:34+00:00\",\"dateModified\":\"2022-06-17T07:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/\"},\"wordCount\":798,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#organization\"},\"keywords\":[\"Dijital d\u00f6n\u00fc\u015f\u00fcmle\",\"Dijitalle\u015fme\",\"End\u00fcstri 4.0\",\"VDI\/VDE 4000\"],\"articleSection\":[\"Optimizasyon\",\"Otomasyon\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/\",\"name\":\"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri - Violett Zeller ile r\u00f6portaj - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#website\"},\"datePublished\":\"2021-08-11T06:17:34+00:00\",\"dateModified\":\"2022-06-17T07:03:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Just another blogs.yokogawa.com Sites site\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/person\/1f3b3ff3511df254fa00b2c9813ae815\",\"name\":\"Silke M\u00fcller\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/person\/image\/8a8a675bcb3e2c343d2370776ca279d7\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/24c6681830f2e0554556d87c7a263564?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/24c6681830f2e0554556d87c7a263564?s=96&d=mm&r=g\",\"caption\":\"Silke M\u00fcller\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/author\/silke-mueller\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri - Violett Zeller ile r\u00f6portaj - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/","og_locale":"tr_TR","og_type":"article","og_title":"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri - Violett Zeller ile r\u00f6portaj","og_description":"Dijital d\u00f6n\u00fc\u015f\u00fcme giren \u015firketler i\u00e7in bir\u00e7ok farkl\u0131 soru b\u00fcy\u00fck zorluklar do\u011furuyor. Olgunluk modelleri, bunlara cevap vermede b\u00fcy\u00fck destek sa\u011flayabilir. Ancak daha sonra bile, mevcut stratejileri de\u011fi\u015fen ko\u015fullara \u00e7evik bir \u015fekilde adapte edebilmek i\u00e7in g\u00fcncel durumun incelenmesi \u015fartt\u0131r. #VDI \/ #VDE&hellip;  Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj Devam\u0131 &raquo;","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2021-08-11T06:17:34+00:00","article_modified_time":"2022-06-17T07:03:10+00:00","og_image":[{"width":843,"height":429,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM.png","type":"image\/png"}],"author":"Silke M\u00fcller","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/"},"author":{"name":"Silke M\u00fcller","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/person\/1f3b3ff3511df254fa00b2c9813ae815"},"headline":"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj","datePublished":"2021-08-11T06:17:34+00:00","dateModified":"2022-06-17T07:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/"},"wordCount":798,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#organization"},"keywords":["Dijital d\u00f6n\u00fc\u015f\u00fcmle","Dijitalle\u015fme","End\u00fcstri 4.0","VDI\/VDE 4000"],"articleSection":["Optimizasyon","Otomasyon"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/","name":"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri - Violett Zeller ile r\u00f6portaj - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#website"},"datePublished":"2021-08-11T06:17:34+00:00","dateModified":"2022-06-17T07:03:10+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/dijital-donusumde-olgunluk-derecesi-modelleri-violett-zeller-ile-roportaj\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/"},{"@type":"ListItem","position":2,"name":"Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/","name":"Chemical Pharma Blog","description":"Just another blogs.yokogawa.com Sites site","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/person\/1f3b3ff3511df254fa00b2c9813ae815","name":"Silke M\u00fcller","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/#\/schema\/person\/image\/8a8a675bcb3e2c343d2370776ca279d7","url":"https:\/\/secure.gravatar.com\/avatar\/24c6681830f2e0554556d87c7a263564?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/24c6681830f2e0554556d87c7a263564?s=96&d=mm&r=g","caption":"Silke M\u00fcller"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/author\/silke-mueller\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM.png",843,429,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM-150x150.png",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM-300x153.png",300,153,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM-768x391.png",768,391,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM.png",843,429,false],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM.png",843,429,false],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM.png",843,429,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/DX-SM-356x200.png",356,200,true]},"uagb_author_info":{"display_name":"Silke M\u00fcller","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/author\/silke-mueller\/"},"uagb_comment_info":0,"uagb_excerpt":"Dijital d\u00f6n\u00fc\u015f\u00fcme giren \u015firketler i\u00e7in bir\u00e7ok farkl\u0131 soru b\u00fcy\u00fck zorluklar do\u011furuyor. Olgunluk modelleri, bunlara cevap vermede b\u00fcy\u00fck destek sa\u011flayabilir. Ancak daha sonra bile, mevcut stratejileri de\u011fi\u015fen ko\u015fullara \u00e7evik bir \u015fekilde adapte edebilmek i\u00e7in g\u00fcncel durumun incelenmesi \u015fartt\u0131r. #VDI \/ #VDE&hellip; Dijital d\u00f6n\u00fc\u015f\u00fcmde olgunluk derecesi modelleri &#8211; Violett Zeller ile r\u00f6portaj Devam\u0131 &raquo;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/posts\/11020"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/users\/115"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/comments?post=11020"}],"version-history":[{"count":0,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/posts\/11020\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/media\/9171"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/media?parent=11020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/categories?post=11020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/tags?post=11020"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/tr\/wp-json\/wp\/v2\/coauthors?post=11020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}